Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Alzheimer Disease | 49 | 2019 | 470 | 6.000 |
Why?
|
Oxidative Stress | 31 | 2012 | 446 | 2.750 |
Why?
|
Genome | 11 | 2021 | 371 | 2.470 |
Why?
|
Biological Evolution | 15 | 2023 | 917 | 2.380 |
Why?
|
Lemur | 5 | 2021 | 12 | 2.220 |
Why?
|
Evolution, Molecular | 19 | 2021 | 813 | 2.170 |
Why?
|
Primates | 6 | 2020 | 151 | 2.000 |
Why?
|
Genome, Human | 13 | 2021 | 756 | 1.970 |
Why?
|
Aging | 11 | 2016 | 689 | 1.750 |
Why?
|
Gene Dosage | 10 | 2012 | 207 | 1.640 |
Why?
|
tau Proteins | 16 | 2019 | 62 | 1.610 |
Why?
|
Pan troglodytes | 8 | 2014 | 197 | 1.440 |
Why?
|
Genetics, Population | 8 | 2021 | 394 | 1.390 |
Why?
|
Amyloid beta-Peptides | 20 | 2019 | 203 | 1.390 |
Why?
|
Genetic Variation | 17 | 2017 | 1349 | 1.380 |
Why?
|
Genomics | 7 | 2021 | 710 | 1.320 |
Why?
|
Brain | 23 | 2021 | 2211 | 1.140 |
Why?
|
Neurodegenerative Diseases | 6 | 2019 | 43 | 1.120 |
Why?
|
Extinction, Biological | 5 | 2021 | 85 | 1.120 |
Why?
|
Paleontology | 3 | 2015 | 81 | 1.110 |
Why?
|
Adaptation, Physiological | 7 | 2023 | 306 | 1.100 |
Why?
|
Hominidae | 4 | 2017 | 95 | 1.070 |
Why?
|
Animals | 63 | 2021 | 26518 | 1.050 |
Why?
|
Selection, Genetic | 6 | 2021 | 502 | 1.050 |
Why?
|
Body Size | 2 | 2014 | 91 | 0.980 |
Why?
|
Phylogeny | 12 | 2021 | 1136 | 0.860 |
Why?
|
DNA | 7 | 2015 | 1293 | 0.840 |
Why?
|
Oxidation-Reduction | 11 | 2013 | 373 | 0.810 |
Why?
|
Anthropology, Physical | 1 | 2021 | 14 | 0.800 |
Why?
|
Humans | 107 | 2023 | 86281 | 0.800 |
Why?
|
Tauopathies | 2 | 2019 | 9 | 0.790 |
Why?
|
Neurons | 17 | 2012 | 1545 | 0.790 |
Why?
|
Strepsirhini | 2 | 2017 | 6 | 0.770 |
Why?
|
Urban Renewal | 1 | 2020 | 2 | 0.750 |
Why?
|
Brain Injuries, Traumatic | 2 | 2019 | 86 | 0.730 |
Why?
|
Genetic Markers | 3 | 2017 | 476 | 0.730 |
Why?
|
Neurofibrillary Tangles | 13 | 2014 | 45 | 0.730 |
Why?
|
Species Specificity | 11 | 2020 | 678 | 0.640 |
Why?
|
Sequence Analysis, DNA | 10 | 2017 | 853 | 0.630 |
Why?
|
Plaque, Amyloid | 9 | 2014 | 56 | 0.630 |
Why?
|
Echolocation | 1 | 2017 | 6 | 0.620 |
Why?
|
Color Vision | 3 | 2017 | 15 | 0.620 |
Why?
|
Pattern Recognition, Physiological | 1 | 2017 | 8 | 0.620 |
Why?
|
Microsatellite Repeats | 1 | 2017 | 141 | 0.610 |
Why?
|
Boxing | 1 | 2017 | 1 | 0.600 |
Why?
|
Genotyping Techniques | 1 | 2017 | 68 | 0.600 |
Why?
|
Behavior, Animal | 1 | 2020 | 373 | 0.590 |
Why?
|
RNA | 3 | 2012 | 560 | 0.590 |
Why?
|
Rod Opsins | 4 | 2017 | 9 | 0.580 |
Why?
|
Iron | 6 | 2013 | 163 | 0.550 |
Why?
|
DNA, Mitochondrial | 3 | 2017 | 183 | 0.550 |
Why?
|
Dementia | 2 | 2017 | 187 | 0.530 |
Why?
|
Lipid Peroxidation | 3 | 2011 | 44 | 0.530 |
Why?
|
Base Sequence | 8 | 2021 | 2329 | 0.530 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 455 | 0.510 |
Why?
|
Brain Injuries | 1 | 2017 | 160 | 0.500 |
Why?
|
Apolipoprotein E4 | 2 | 2013 | 27 | 0.500 |
Why?
|
Growth Disorders | 1 | 2014 | 63 | 0.490 |
Why?
|
Pathology | 2 | 2011 | 30 | 0.480 |
Why?
|
Cell Nucleus | 2 | 2021 | 579 | 0.480 |
Why?
|
Aldehydes | 2 | 2011 | 17 | 0.470 |
Why?
|
Plasmodium falciparum | 1 | 2013 | 47 | 0.470 |
Why?
|
Darkness | 2 | 2017 | 49 | 0.460 |
Why?
|
Madagascar | 6 | 2017 | 27 | 0.460 |
Why?
|
Antioxidants | 5 | 2010 | 223 | 0.450 |
Why?
|
Erythrocytes | 1 | 2013 | 255 | 0.440 |
Why?
|
Dementia, Vascular | 1 | 2012 | 7 | 0.430 |
Why?
|
Prion Diseases | 3 | 2010 | 32 | 0.420 |
Why?
|
Histocytochemistry | 1 | 2012 | 130 | 0.420 |
Why?
|
Feeding Behavior | 1 | 2015 | 324 | 0.420 |
Why?
|
Models, Neurological | 2 | 2012 | 405 | 0.390 |
Why?
|
DNA Damage | 1 | 2012 | 362 | 0.390 |
Why?
|
Nerve Degeneration | 4 | 2009 | 83 | 0.380 |
Why?
|
DNA Repair | 1 | 2012 | 356 | 0.380 |
Why?
|
Hippocampus | 8 | 2014 | 442 | 0.380 |
Why?
|
Molecular Sequence Data | 8 | 2015 | 3029 | 0.370 |
Why?
|
Sequence Analysis, RNA | 1 | 2011 | 217 | 0.370 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2009 | 9 | 0.370 |
Why?
|
Diet | 5 | 2023 | 442 | 0.360 |
Why?
|
Parkinson Disease | 5 | 2011 | 132 | 0.360 |
Why?
|
Mitochondria | 5 | 2015 | 535 | 0.360 |
Why?
|
Forests | 4 | 2021 | 20 | 0.350 |
Why?
|
Protein Processing, Post-Translational | 1 | 2011 | 371 | 0.350 |
Why?
|
Feces | 1 | 2010 | 316 | 0.340 |
Why?
|
Models, Genetic | 5 | 2017 | 926 | 0.340 |
Why?
|
Body Height | 1 | 2009 | 99 | 0.330 |
Why?
|
Tandem Repeat Sequences | 1 | 2008 | 26 | 0.320 |
Why?
|
alpha-Amylases | 1 | 2007 | 2 | 0.320 |
Why?
|
Disaster Planning | 2 | 2008 | 24 | 0.320 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2017 | 2350 | 0.310 |
Why?
|
Transcriptome | 1 | 2011 | 574 | 0.300 |
Why?
|
Immunohistochemistry | 13 | 2019 | 1752 | 0.300 |
Why?
|
Fossils | 3 | 2015 | 335 | 0.300 |
Why?
|
Phenotype | 7 | 2015 | 2375 | 0.300 |
Why?
|
Chromosomes, Human, Y | 1 | 2007 | 22 | 0.300 |
Why?
|
Circadian Rhythm | 1 | 2009 | 303 | 0.300 |
Why?
|
Aged, 80 and over | 18 | 2019 | 6481 | 0.290 |
Why?
|
Independent Living | 1 | 2016 | 18 | 0.290 |
Why?
|
Sequence Alignment | 4 | 2015 | 351 | 0.290 |
Why?
|
Copper | 2 | 2004 | 71 | 0.280 |
Why?
|
Neanderthals | 2 | 2017 | 15 | 0.280 |
Why?
|
PAX9 Transcription Factor | 1 | 2005 | 2 | 0.280 |
Why?
|
MSX1 Transcription Factor | 1 | 2005 | 3 | 0.280 |
Why?
|
Color Perception | 1 | 2007 | 117 | 0.280 |
Why?
|
Nerve Tissue Proteins | 5 | 2012 | 503 | 0.270 |
Why?
|
Gene Deletion | 1 | 2007 | 328 | 0.270 |
Why?
|
Trust | 1 | 2016 | 95 | 0.270 |
Why?
|
Substance Abuse, Intravenous | 1 | 2016 | 54 | 0.270 |
Why?
|
Endangered Species | 2 | 2017 | 23 | 0.260 |
Why?
|
Regulatory Elements, Transcriptional | 2 | 2017 | 45 | 0.260 |
Why?
|
Social Environment | 1 | 2016 | 188 | 0.260 |
Why?
|
Metals | 1 | 2005 | 90 | 0.260 |
Why?
|
Community Health Services | 1 | 2016 | 80 | 0.260 |
Why?
|
Social Support | 1 | 2016 | 193 | 0.250 |
Why?
|
Influenza, Human | 2 | 2008 | 329 | 0.250 |
Why?
|
Lewy Body Disease | 3 | 2010 | 8 | 0.250 |
Why?
|
Aged | 23 | 2019 | 18353 | 0.240 |
Why?
|
Microtubules | 2 | 2004 | 117 | 0.240 |
Why?
|
Olfactory Mucosa | 1 | 2003 | 33 | 0.230 |
Why?
|
beta-Defensins | 2 | 2013 | 12 | 0.230 |
Why?
|
History, 21st Century | 3 | 2012 | 175 | 0.220 |
Why?
|
Reactive Oxygen Species | 5 | 2012 | 480 | 0.220 |
Why?
|
History, 20th Century | 3 | 2012 | 312 | 0.210 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2013 | 689 | 0.210 |
Why?
|
Geography | 2 | 2013 | 223 | 0.200 |
Why?
|
Guanosine | 3 | 2009 | 29 | 0.200 |
Why?
|
Middle Aged | 21 | 2019 | 24957 | 0.200 |
Why?
|
Biomarkers | 4 | 2014 | 1709 | 0.200 |
Why?
|
Poverty | 2 | 2016 | 171 | 0.200 |
Why?
|
Cebus | 1 | 2021 | 17 | 0.200 |
Why?
|
Publications | 1 | 2021 | 26 | 0.200 |
Why?
|
Longevity | 1 | 2021 | 51 | 0.190 |
Why?
|
Macaca mulatta | 3 | 2014 | 459 | 0.190 |
Why?
|
Male | 24 | 2019 | 40860 | 0.190 |
Why?
|
Membrane Proteins | 3 | 2017 | 1194 | 0.190 |
Why?
|
Disease Outbreaks | 2 | 2008 | 154 | 0.190 |
Why?
|
Metagenomics | 1 | 2021 | 83 | 0.190 |
Why?
|
Adaptation, Biological | 1 | 2021 | 85 | 0.190 |
Why?
|
Brain Chemistry | 4 | 2008 | 121 | 0.180 |
Why?
|
Horses | 1 | 2019 | 35 | 0.180 |
Why?
|
Gene Expression Regulation | 5 | 2017 | 1917 | 0.180 |
Why?
|
Forensic Pathology | 1 | 2019 | 3 | 0.170 |
Why?
|
Pyramidal Cells | 3 | 2011 | 80 | 0.170 |
Why?
|
Adaptation, Psychological | 1 | 2020 | 157 | 0.170 |
Why?
|
Chronic Traumatic Encephalopathy | 1 | 2019 | 2 | 0.170 |
Why?
|
Post-Concussion Syndrome | 1 | 2019 | 7 | 0.170 |
Why?
|
Symbiosis | 1 | 2020 | 118 | 0.170 |
Why?
|
Microscopy, Electron | 2 | 2013 | 502 | 0.170 |
Why?
|
Haplotypes | 1 | 2021 | 642 | 0.170 |
Why?
|
Ecosystem | 2 | 2020 | 315 | 0.170 |
Why?
|
Polymorphism, Genetic | 3 | 2017 | 819 | 0.160 |
Why?
|
Prions | 2 | 2010 | 54 | 0.160 |
Why?
|
Brain Concussion | 1 | 2019 | 59 | 0.160 |
Why?
|
Liver | 2 | 2014 | 1229 | 0.160 |
Why?
|
Dolphins | 1 | 2017 | 3 | 0.160 |
Why?
|
Tarsiidae | 1 | 2017 | 1 | 0.150 |
Why?
|
Sympatry | 1 | 2017 | 9 | 0.150 |
Why?
|
Military Personnel | 1 | 2019 | 85 | 0.150 |
Why?
|
Lemuridae | 1 | 2017 | 5 | 0.150 |
Why?
|
HIV Infections | 1 | 2016 | 768 | 0.150 |
Why?
|
Metabolomics | 2 | 2014 | 67 | 0.150 |
Why?
|
Chitin | 2 | 2007 | 10 | 0.150 |
Why?
|
Genome, Mitochondrial | 1 | 2017 | 26 | 0.150 |
Why?
|
Choroid Plexus | 2 | 2013 | 14 | 0.150 |
Why?
|
Social Justice | 1 | 2007 | 49 | 0.150 |
Why?
|
Phosphorylation | 4 | 2012 | 1101 | 0.150 |
Why?
|
DNA Primers | 2 | 2008 | 542 | 0.150 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 266 | 0.150 |
Why?
|
DNA Transposable Elements | 1 | 2017 | 169 | 0.150 |
Why?
|
Brain Stem | 2 | 2011 | 165 | 0.150 |
Why?
|
Seed Dispersal | 1 | 2016 | 1 | 0.140 |
Why?
|
Baltimore | 2 | 2016 | 36 | 0.140 |
Why?
|
Amyloid | 2 | 2009 | 85 | 0.140 |
Why?
|
Chiroptera | 1 | 2017 | 51 | 0.140 |
Why?
|
Opsins | 1 | 2016 | 10 | 0.140 |
Why?
|
Trees | 1 | 2016 | 30 | 0.140 |
Why?
|
Female | 21 | 2019 | 44405 | 0.140 |
Why?
|
Referral and Consultation | 1 | 2019 | 326 | 0.140 |
Why?
|
Mammoths | 1 | 2015 | 1 | 0.140 |
Why?
|
Genetic Speciation | 1 | 2017 | 113 | 0.130 |
Why?
|
Brain Injury, Chronic | 1 | 2015 | 9 | 0.130 |
Why?
|
Amino Acid Sequence | 3 | 2015 | 2062 | 0.130 |
Why?
|
Disease Progression | 3 | 2017 | 1531 | 0.130 |
Why?
|
Terminology as Topic | 1 | 2017 | 217 | 0.130 |
Why?
|
Duffy Blood-Group System | 1 | 2014 | 7 | 0.130 |
Why?
|
Myosin Heavy Chains | 1 | 2015 | 88 | 0.130 |
Why?
|
Uganda | 1 | 2014 | 34 | 0.130 |
Why?
|
Residence Characteristics | 2 | 2016 | 195 | 0.120 |
Why?
|
Apolipoprotein E3 | 1 | 2013 | 7 | 0.120 |
Why?
|
Metabolic Networks and Pathways | 1 | 2014 | 78 | 0.120 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2015 | 114 | 0.120 |
Why?
|
Agriculture | 1 | 2014 | 38 | 0.120 |
Why?
|
Healthcare Disparities | 1 | 2008 | 369 | 0.120 |
Why?
|
DNA Copy Number Variations | 1 | 2015 | 171 | 0.120 |
Why?
|
Time Factors | 3 | 2017 | 5198 | 0.120 |
Why?
|
Cerebrovascular Circulation | 1 | 2015 | 212 | 0.120 |
Why?
|
Amyloidosis | 2 | 2012 | 115 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2014 | 286 | 0.110 |
Why?
|
Platyrrhini | 1 | 2012 | 2 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2014 | 162 | 0.110 |
Why?
|
DNA, Intergenic | 1 | 2012 | 25 | 0.110 |
Why?
|
Pseudogenes | 1 | 2012 | 35 | 0.110 |
Why?
|
Case-Control Studies | 3 | 2011 | 1801 | 0.110 |
Why?
|
Nucleic Acid Hybridization | 3 | 2008 | 245 | 0.110 |
Why?
|
Systems Biology | 1 | 2012 | 42 | 0.110 |
Why?
|
Gene Frequency | 1 | 2014 | 676 | 0.110 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2012 | 13 | 0.110 |
Why?
|
Models, Statistical | 1 | 2016 | 574 | 0.110 |
Why?
|
Genotype | 3 | 2013 | 1850 | 0.110 |
Why?
|
RNA, Untranslated | 1 | 2012 | 63 | 0.110 |
Why?
|
Lipofuscin | 1 | 2011 | 2 | 0.110 |
Why?
|
Microscopy, Immunoelectron | 1 | 2011 | 29 | 0.110 |
Why?
|
Treatment Failure | 1 | 2012 | 284 | 0.100 |
Why?
|
Ribosomal Protein S6 | 1 | 2011 | 4 | 0.100 |
Why?
|
Neurobiology | 1 | 2011 | 10 | 0.100 |
Why?
|
Gene Regulatory Networks | 1 | 2014 | 291 | 0.100 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2011 | 12 | 0.100 |
Why?
|
Open Reading Frames | 1 | 2011 | 117 | 0.100 |
Why?
|
Cytoplasmic Granules | 1 | 2011 | 94 | 0.100 |
Why?
|
Nucleotides | 1 | 2011 | 95 | 0.100 |
Why?
|
Retinoblastoma Protein | 1 | 2011 | 66 | 0.100 |
Why?
|
Adult | 10 | 2019 | 25577 | 0.100 |
Why?
|
GTP Phosphohydrolases | 1 | 2011 | 71 | 0.100 |
Why?
|
Dogs | 1 | 2011 | 684 | 0.100 |
Why?
|
Cells, Cultured | 2 | 2013 | 2810 | 0.100 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.100 |
Why?
|
Internet | 1 | 2013 | 309 | 0.100 |
Why?
|
Energy Metabolism | 1 | 2012 | 271 | 0.100 |
Why?
|
CD3 Complex | 1 | 2010 | 135 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2012 | 584 | 0.090 |
Why?
|
Amino Acid Substitution | 2 | 2015 | 339 | 0.090 |
Why?
|
Paraffin Embedding | 1 | 2010 | 78 | 0.090 |
Why?
|
Mitochondrial Proteins | 1 | 2011 | 123 | 0.090 |
Why?
|
Peptide Hydrolases | 1 | 2010 | 100 | 0.090 |
Why?
|
Exercise | 1 | 2013 | 315 | 0.090 |
Why?
|
Microtubule-Associated Proteins | 1 | 2011 | 176 | 0.090 |
Why?
|
Cell Cycle | 2 | 2009 | 502 | 0.090 |
Why?
|
Kynurenine | 1 | 2010 | 20 | 0.090 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 927 | 0.090 |
Why?
|
Immunoblotting | 1 | 2010 | 267 | 0.090 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 54 | 0.090 |
Why?
|
Caloric Restriction | 1 | 2009 | 14 | 0.090 |
Why?
|
Heredodegenerative Disorders, Nervous System | 1 | 2009 | 4 | 0.090 |
Why?
|
DNA Mutational Analysis | 2 | 2010 | 526 | 0.090 |
Why?
|
Carrier Proteins | 2 | 2010 | 672 | 0.090 |
Why?
|
S Phase | 1 | 2009 | 62 | 0.090 |
Why?
|
Growth | 1 | 2009 | 43 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2006 | 763 | 0.090 |
Why?
|
Superoxide Dismutase-1 | 1 | 2009 | 48 | 0.090 |
Why?
|
Genes, myc | 1 | 2009 | 39 | 0.090 |
Why?
|
Neocortex | 3 | 2006 | 95 | 0.080 |
Why?
|
Hypoxia, Brain | 1 | 2009 | 41 | 0.080 |
Why?
|
Comparative Genomic Hybridization | 1 | 2008 | 39 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2008 | 66 | 0.080 |
Why?
|
Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.080 |
Why?
|
Ceruloplasmin | 1 | 2008 | 9 | 0.080 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 2009 | 143 | 0.080 |
Why?
|
Superoxide Dismutase | 1 | 2009 | 177 | 0.080 |
Why?
|
Starch | 1 | 2007 | 8 | 0.080 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2008 | 348 | 0.080 |
Why?
|
United States | 3 | 2019 | 6637 | 0.080 |
Why?
|
Polysaccharides | 1 | 2007 | 89 | 0.080 |
Why?
|
Xanthomatosis, Cerebrotendinous | 1 | 2007 | 3 | 0.080 |
Why?
|
Genomic Imprinting | 1 | 2007 | 33 | 0.080 |
Why?
|
Pan paniscus | 1 | 2007 | 10 | 0.080 |
Why?
|
Biomedical Research | 1 | 2011 | 375 | 0.080 |
Why?
|
Antigens | 1 | 2008 | 228 | 0.070 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2012 | 929 | 0.070 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2006 | 7 | 0.070 |
Why?
|
Gorilla gorilla | 1 | 2007 | 40 | 0.070 |
Why?
|
Synapses | 1 | 2009 | 265 | 0.070 |
Why?
|
Genome-Wide Association Study | 1 | 2014 | 1611 | 0.070 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2007 | 93 | 0.070 |
Why?
|
Family | 1 | 2008 | 311 | 0.070 |
Why?
|
Antibodies | 1 | 2008 | 349 | 0.070 |
Why?
|
Geographic Information Systems | 1 | 2016 | 20 | 0.070 |
Why?
|
Social Isolation | 1 | 2016 | 67 | 0.070 |
Why?
|
Needle-Exchange Programs | 1 | 2016 | 18 | 0.070 |
Why?
|
Health Priorities | 1 | 2016 | 23 | 0.070 |
Why?
|
Urban Health | 1 | 2016 | 55 | 0.070 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2005 | 25 | 0.070 |
Why?
|
Cell Cycle Proteins | 2 | 2009 | 388 | 0.070 |
Why?
|
Glycation End Products, Advanced | 1 | 2005 | 13 | 0.070 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 86 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 2016 | 202 | 0.070 |
Why?
|
Interviews as Topic | 1 | 2016 | 319 | 0.070 |
Why?
|
Adolescent | 3 | 2014 | 8968 | 0.070 |
Why?
|
Likelihood Functions | 1 | 2005 | 251 | 0.070 |
Why?
|
Nitric Oxide | 1 | 2006 | 277 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 1168 | 0.060 |
Why?
|
Young Adult | 5 | 2019 | 5961 | 0.060 |
Why?
|
Disease Models, Animal | 2 | 2009 | 2227 | 0.060 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 2004 | 8 | 0.060 |
Why?
|
Urban Population | 1 | 2016 | 213 | 0.060 |
Why?
|
Lysine | 1 | 2005 | 147 | 0.060 |
Why?
|
Mice | 4 | 2011 | 11313 | 0.060 |
Why?
|
Cyclin B | 1 | 2004 | 17 | 0.060 |
Why?
|
Glioma | 1 | 2006 | 285 | 0.060 |
Why?
|
Blood Vessels | 1 | 2004 | 94 | 0.060 |
Why?
|
Cyclins | 1 | 2004 | 82 | 0.060 |
Why?
|
Recombination, Genetic | 1 | 2006 | 439 | 0.060 |
Why?
|
Autopsy | 2 | 2019 | 116 | 0.060 |
Why?
|
Heme Oxygenase-1 | 1 | 2003 | 19 | 0.060 |
Why?
|
Pilot Projects | 1 | 2016 | 837 | 0.060 |
Why?
|
Rainforest | 1 | 2023 | 8 | 0.060 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 44 | 0.060 |
Why?
|
Hydroxyl Radical | 1 | 2003 | 35 | 0.060 |
Why?
|
Electron Transport Complex IV | 1 | 2003 | 47 | 0.060 |
Why?
|
Acclimatization | 1 | 2023 | 76 | 0.060 |
Why?
|
Multiple System Atrophy | 1 | 2002 | 4 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2016 | 392 | 0.050 |
Why?
|
Deoxyguanosine | 1 | 2002 | 28 | 0.050 |
Why?
|
Hydrocephalus | 1 | 2003 | 101 | 0.050 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 2267 | 0.050 |
Why?
|
Quality Improvement | 1 | 2016 | 423 | 0.050 |
Why?
|
Herbivory | 1 | 2021 | 25 | 0.050 |
Why?
|
RNA, Ribosomal | 2 | 2011 | 60 | 0.050 |
Why?
|
Computer Simulation | 2 | 2016 | 1077 | 0.050 |
Why?
|
Amino Acids | 1 | 2021 | 252 | 0.050 |
Why?
|
Asthma | 1 | 2008 | 947 | 0.050 |
Why?
|
Excitatory Amino Acid Antagonists | 2 | 2011 | 78 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 877 | 0.040 |
Why?
|
Biopsy | 1 | 2003 | 1160 | 0.040 |
Why?
|
Cholinesterase Inhibitors | 2 | 2010 | 45 | 0.040 |
Why?
|
Chromosome Mapping | 3 | 2006 | 1074 | 0.040 |
Why?
|
Astrocytes | 2 | 2012 | 139 | 0.040 |
Why?
|
Veterans Health | 1 | 2019 | 15 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2021 | 679 | 0.040 |
Why?
|
Blotting, Western | 2 | 2011 | 781 | 0.040 |
Why?
|
Risk Factors | 2 | 2016 | 5397 | 0.040 |
Why?
|
Social Responsibility | 1 | 2008 | 57 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2008 | 76 | 0.040 |
Why?
|
Callithrix | 1 | 2017 | 11 | 0.040 |
Why?
|
Up-Regulation | 2 | 2013 | 710 | 0.040 |
Why?
|
Borneo | 1 | 2017 | 1 | 0.040 |
Why?
|
Bibliometrics | 1 | 2007 | 36 | 0.040 |
Why?
|
Policy Making | 1 | 2007 | 62 | 0.040 |
Why?
|
Cell Line | 2 | 2012 | 2466 | 0.040 |
Why?
|
Phylogeography | 1 | 2017 | 41 | 0.040 |
Why?
|
Cytoplasm | 2 | 2009 | 281 | 0.040 |
Why?
|
Global Health | 1 | 2008 | 193 | 0.040 |
Why?
|
Climate | 1 | 2017 | 50 | 0.040 |
Why?
|
Cell Death | 2 | 2008 | 256 | 0.040 |
Why?
|
Gene Expression | 2 | 2014 | 1281 | 0.040 |
Why?
|
Opossums | 1 | 2016 | 4 | 0.040 |
Why?
|
Arctic Regions | 1 | 2015 | 5 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2015 | 17 | 0.030 |
Why?
|
TRPV Cation Channels | 1 | 2015 | 15 | 0.030 |
Why?
|
Elephants | 1 | 2015 | 16 | 0.030 |
Why?
|
Environment | 1 | 2017 | 219 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2015 | 67 | 0.030 |
Why?
|
Mental Disorders | 1 | 2019 | 371 | 0.030 |
Why?
|
Africa, Southern | 1 | 2014 | 1 | 0.030 |
Why?
|
Gene Expression Profiling | 2 | 2014 | 1381 | 0.030 |
Why?
|
Ultraviolet Rays | 1 | 2016 | 193 | 0.030 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 21 | 0.030 |
Why?
|
Genetic Drift | 1 | 2014 | 37 | 0.030 |
Why?
|
Demography | 1 | 2014 | 177 | 0.030 |
Why?
|
Africa, Central | 1 | 2014 | 4 | 0.030 |
Why?
|
Africa, Western | 1 | 2014 | 10 | 0.030 |
Why?
|
Cooking | 1 | 2014 | 53 | 0.030 |
Why?
|
Lactic Acid | 1 | 2013 | 90 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 736 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2015 | 615 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2009 | 694 | 0.030 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 424 | 0.030 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 151 | 0.030 |
Why?
|
Central Nervous System Diseases | 1 | 2012 | 52 | 0.030 |
Why?
|
Chemotaxis | 1 | 2012 | 72 | 0.030 |
Why?
|
Organ Size | 1 | 2012 | 363 | 0.030 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2011 | 58 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 29 | 0.030 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2011 | 44 | 0.030 |
Why?
|
Adenosine Diphosphate | 1 | 2011 | 55 | 0.030 |
Why?
|
Microglia | 1 | 2012 | 102 | 0.030 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2011 | 20 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2012 | 154 | 0.030 |
Why?
|
Risk Assessment | 1 | 2019 | 2253 | 0.020 |
Why?
|
Lewy Bodies | 1 | 2010 | 1 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2010 | 13 | 0.020 |
Why?
|
Inclusion Bodies | 1 | 2010 | 34 | 0.020 |
Why?
|
Dynamins | 1 | 2011 | 48 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2012 | 164 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 314 | 0.020 |
Why?
|
Gene Silencing | 1 | 2011 | 172 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2010 | 40 | 0.020 |
Why?
|
Culture | 1 | 2010 | 53 | 0.020 |
Why?
|
Formaldehyde | 1 | 2010 | 52 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 314 | 0.020 |
Why?
|
Child | 2 | 2014 | 6913 | 0.020 |
Why?
|
RNA Interference | 1 | 2011 | 368 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 2011 | 242 | 0.020 |
Why?
|
Wound Healing | 1 | 2012 | 342 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2011 | 438 | 0.020 |
Why?
|
Minichromosome Maintenance Complex Component 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
Autophagy | 1 | 2011 | 148 | 0.020 |
Why?
|
Transfection | 1 | 2011 | 895 | 0.020 |
Why?
|
Maze Learning | 1 | 2009 | 28 | 0.020 |
Why?
|
Presenilins | 1 | 2008 | 6 | 0.020 |
Why?
|
Cell Survival | 1 | 2011 | 966 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2012 | 424 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2012 | 405 | 0.020 |
Why?
|
Immunologic Techniques | 1 | 2008 | 27 | 0.020 |
Why?
|
Nerve Growth Factor | 1 | 2008 | 17 | 0.020 |
Why?
|
Brain Diseases, Metabolic, Inborn | 1 | 2008 | 2 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2014 | 2369 | 0.020 |
Why?
|
Cytokines | 1 | 2012 | 775 | 0.020 |
Why?
|
Heparitin Sulfate | 1 | 2007 | 27 | 0.020 |
Why?
|
Antigen-Antibody Complex | 1 | 2008 | 87 | 0.020 |
Why?
|
Protein Transport | 1 | 2009 | 410 | 0.020 |
Why?
|
Infant | 1 | 2014 | 3036 | 0.020 |
Why?
|
Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
Biological Transport, Active | 1 | 2007 | 101 | 0.020 |
Why?
|
Extraembryonic Membranes | 1 | 2007 | 8 | 0.020 |
Why?
|
Synteny | 1 | 2007 | 25 | 0.020 |
Why?
|
Cholestanetriol 26-Monooxygenase | 1 | 2007 | 6 | 0.020 |
Why?
|
DNA Fingerprinting | 1 | 2006 | 16 | 0.020 |
Why?
|
Child, Preschool | 1 | 2014 | 3608 | 0.020 |
Why?
|
Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
Achilles Tendon | 1 | 2007 | 15 | 0.020 |
Why?
|
Gene Duplication | 1 | 2008 | 125 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2006 | 63 | 0.020 |
Why?
|
DNA (Cytosine-5-)-Methyltransferases | 1 | 2007 | 55 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2009 | 236 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2009 | 460 | 0.020 |
Why?
|
Hormones | 1 | 2007 | 140 | 0.020 |
Why?
|
CpG Islands | 1 | 2007 | 150 | 0.020 |
Why?
|
Huntingtin Protein | 1 | 2006 | 10 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2006 | 216 | 0.020 |
Why?
|
Vitamin E | 1 | 2006 | 35 | 0.020 |
Why?
|
Huntington Disease | 1 | 2006 | 37 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2006 | 69 | 0.020 |
Why?
|
Neuroglia | 1 | 2006 | 104 | 0.020 |
Why?
|
Genetic Testing | 1 | 2010 | 535 | 0.020 |
Why?
|
Nitric Oxide Synthase | 1 | 2006 | 125 | 0.020 |
Why?
|
Vaccination | 1 | 2008 | 253 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2007 | 293 | 0.020 |
Why?
|
Syndrome | 1 | 2007 | 446 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2012 | 1571 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2007 | 147 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2007 | 196 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 241 | 0.020 |
Why?
|
Neuroprotective Agents | 1 | 2006 | 94 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2006 | 98 | 0.020 |
Why?
|
Abnormalities, Multiple | 1 | 2007 | 232 | 0.020 |
Why?
|
Apoptosis | 1 | 2012 | 1678 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2005 | 66 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 473 | 0.020 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2011 | 1200 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2009 | 1537 | 0.020 |
Why?
|
Histones | 1 | 2007 | 309 | 0.020 |
Why?
|
Rats | 1 | 2011 | 3984 | 0.020 |
Why?
|
Research Design | 1 | 2008 | 594 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2004 | 17 | 0.020 |
Why?
|
Matched-Pair Analysis | 1 | 2004 | 43 | 0.020 |
Why?
|
G2 Phase | 1 | 2004 | 34 | 0.020 |
Why?
|
Cytosol | 1 | 2004 | 189 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 576 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 74 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 378 | 0.010 |
Why?
|
Software | 1 | 2008 | 650 | 0.010 |
Why?
|
Mitosis | 1 | 2004 | 151 | 0.010 |
Why?
|
Models, Biological | 1 | 2010 | 1748 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 622 | 0.010 |
Why?
|
Reference Values | 1 | 2004 | 673 | 0.010 |
Why?
|
Inflammation | 1 | 2008 | 913 | 0.010 |
Why?
|
DNA Methylation | 1 | 2007 | 622 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 1376 | 0.010 |
Why?
|
Proteins | 1 | 2007 | 777 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2007 | 1975 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 376 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2006 | 2699 | 0.010 |
Why?
|
Algorithms | 1 | 2006 | 1828 | 0.010 |
Why?
|
Mutation | 1 | 2005 | 3952 | 0.010 |
Why?
|